Table 1 Patient baseline characteristics at the time of study inclusion
Variable | Patients with liver cirrhosis (n = 106) |
|---|---|
Male Gender n (%) | 72 (68%) |
Age of patients (years) median (IQR) | 63 (53; 69) |
Age of caregiver (years) median (IQR) | 59 (47; 66) |
Sodium (mmol/l) median (IQR) | 138 (135; 140) |
Creatinine (mg/dl) median (IQR) | 0.9 (0.8; 1.4) |
Bilirubin (mg/dl) median (IQR) | 1.8 (1; 2.6) |
Albumin (g/l) median (IQR) | 31 (26; 34) |
INR median (IQR) | 1.4 (1.2; 1.6) |
CRP (mg/l) median (IQR) | 8.1 (3.5; 18.5) |
White blood cell count (/nl) median (IQR) | 5.7 (4.6; 7.6) |
Hemoglobin (g/d) median (IQR) | 12.3 (10.2; 13.6) |
Platelets (/nl) median (IQR) | 99 (72; 147) |
MELD median (IQR) | 14 (10; 18) |
Child–Pugh score *A n (%) | 49 (46%) |
*B n (%) | 41 (39%) |
*C n (%) | 16 (15%) |
History of ascites n (%) | 60 (57%) |
History of spontaneous bacterial peritonitis n (%) | 9 (8%) |
History of hepatic encephalopathy n (%) | 28 (26%) |
History of variceal bleeding n (%) | 21 (20%) |
History of hepatorenal syndrome n (%) | 11 (10%) |